The table below shows MADRIGAL PHARMACEUTICALS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$167.44M
-$88.89M
-$149.16M
-$84.07M
-$49.91M
-$43.43M
Capital expenditure
$3.85M
$0.00
$357.00K
$35.00K
$52.00K
$44.00K
Investing cash flow
$192.19M
$163.88M
$98.05M
-$186.86M
$55.93M
-$33.46M
Dividends paid
-
-
-
-
MDGL operating cash flow (10-K history)
MADRIGAL PHARMACEUTICALS, INC. reported operating cash flow of -$189.55M for fiscal year 2025. That is up 58.4% from -$455.57M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$17.61M (FY 2016) to -$189.55M. Figures come from the company's audited annual reports as filed with the SEC.